Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neuromyelitis optica: changing concepts.

Anu Jacob1, Marcelo Matiello, Dean M Wingerchuk

  • 1Department of Neurology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA.

Journal of Neuroimmunology
|May 22, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immunity Gone Viral: Subacute Cognitive Decline With Multifocal Brain Lesions in Neuromyelitis Optica Spectrum Disorder.

Neurology(R) neuroimmunology & neuroinflammation·2026
Same author

Retinal macrophage-like cell activation and ganglion cell layer thinning are associated with disability and MRI lesion burden in multiple sclerosis.

PloS one·2026
Same author

Should autologous HSCT be a first-line option in highly active MS? No.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

Identification of genetic risk loci associated with aquaporin 4-positive neuromyelitis optica spectrum disorder: a genome-wide association study.

The Lancet. Neurology·2026
Same author

Comparative Effectiveness of Disease-Modifying Treatments in Double Seronegative Neuromyelitis Optica Spectrum Disorder.

Neurology(R) neuroimmunology & neuroinflammation·2026
Same author

Cerebrovascular Manifestations of Neurosarcoidosis - An Overview.

Vascular health and risk management·2026
Same journal

Clinical features, imaging findings, and treatment outcomes of optic neuritis associated with anti-CRMP5 antibodies: a systematic review.

Journal of neuroimmunology·2026
Same journal

Serum IDO1 and β-catenin levels in patients with multiple sclerosis with and without atherosclerosis: A case-control study.

Journal of neuroimmunology·2026
Same journal

Neurological sequelae of Long COVID: Pathophysiological mechanisms, diagnostic advances, and therapeutic perspectives.

Journal of neuroimmunology·2026
Same journal

Corrigendum to 'Role of CD40 in prion disease and the immune response to recombinant PrP' [Journal of Neuroimmunology 257 (2013) 21-27/475655].

Journal of neuroimmunology·2026
Same journal

Clinical characteristics of IgG4-related hypertrophic pachymeningitis with and without serum ANCA positivity.

Journal of neuroimmunology·2026
Same journal

Chronic neuroinflammation after acute SARS-Cov-2 infection induces retinal damage in the hACE2 transgenic mouse model.

Journal of neuroimmunology·2026
See all related articles

Neuromyelitis optica (NMO) involves autoimmune attacks on the central nervous system, specifically optic nerves and spinal cord. Research suggests NMO-IgG autoantibodies target aquaporin 4, initiating inflammatory demyelination.

Area of Science:

  • Neuroimmunology
  • Demyelinating diseases
  • Autoimmunity

Background:

  • Neuromyelitis optica (NMO) and NMO spectrum disorders are inflammatory demyelinating diseases affecting the central nervous system.
  • These conditions show a predilection for the optic nerves and spinal cord.
  • Recent identification of NMO-IgG and aquaporin 4 has revitalized NMO research.

Purpose of the Study:

  • To explore the pathogenic mechanisms of Neuromyelitis optica (NMO).
  • To investigate the role of NMO-IgG autoantibodies and aquaporin 4 in disease initiation.

Main Methods:

  • Analysis of current data on NMO pathogenesis.
  • Hypothesizing the role of peripheral B cells, autoantibodies, and complement activation.
  • Considering the development of animal models for further study.

Related Experiment Videos

Main Results:

  • NMO-IgG is identified as a disease-specific marker for NMO.
  • Aquaporin 4 is the primary target antigen in NMO.
  • A proposed mechanism involves autoantibodies binding to aquaporin 4 on astrocyte foot processes, leading to complement activation and subsequent demyelination and necrosis.

Conclusions:

  • Autoantibodies targeting aquaporin 4 are implicated in NMO pathogenesis.
  • Complement activation plays a key role in initiating inflammatory demyelination.
  • Further research with animal models and clinical analysis is needed to fully understand NMO pathobiology and treatment responses.